From the Journals

Intramuscular steroid injection reduced hip OA pain up to 12 weeks

Publish date: March 13, 2018

 

FROM ANNALS OF THE RHEUMATIC DISEASES

SOURCE: Dorleijn D et al. Ann Rheum Dis. 2018 March 7. doi: 10.1136/annrheumdis-2017-212628

Pages

Recommended Reading

FDA approves first extended-release steroid injection for OA knee pain
MDedge Rheumatology
Injectable agent found to improve knee function in OA patients
MDedge Rheumatology
Arthritis prevalence higher than previously thought, especially in adults under 65
MDedge Rheumatology
FDA recommends voluntary recall of Limbrel
MDedge Rheumatology
Evidence builds for long-term ineffectiveness of steroid shots for knee OA
MDedge Rheumatology
Sprifermin shows cartilage-building potential in knee OA patients
MDedge Rheumatology
Arthritis treatment costs per person held steady from 2008 to 2014
MDedge Rheumatology
Turmeric-, frankincense-derived supplement shows OA benefit
MDedge Rheumatology
Experts review the year in rheumatology ... and what lies ahead
MDedge Rheumatology
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
MDedge Rheumatology